Albert Bourla
Chairman and CEO, Pfizer
More from the U.S. Chamber
- Why the U.S. Chamber is Fighting to Protect Amicus Filers
Proposed changes to the federal rules could harm important First Amendment rights and impose unnecessary burdens on amicus filers and federal courts.
- 2025 Economic Preview: A Year of Productivity-Driven Growth
The U.S. Chamber’s Chief Economist outlines how productivity will drive growth in 2025 and create new opportunities for American workers and businesses.
- What to Know About the Department of Energy’s LNG ‘Pause’ Study
The Biden Administration put its thumb on the scale to downplay liquid natural gas (LNG) benefits.
